Prescription Required.
Is the active ingredient.
Treatment of schizophrenia in adults.
Treatment of major depressive disorder (MDD) in adults as an adjunct to antidepressant medication.
Treatment of bipolar depression in adults as an adjunct to antidepressant medication.
Carispec 1.5mg Cap (Cariprazine) is a dopamine D3 and D2 receptor partial agonist. It works by modulating dopamine neurotransmission in the brain, affecting pathways implicated in schizophrenia, MDD, and bipolar depression. The precise mechanism by which it improves symptoms is not fully understood but is believed to be related to its effects on dopamine pathways and potentially other neurotransmitter systems.
Store Cariprazine tablets at room temperature (68-77°F or 20-25°C) in a tightly closed container, away from light and moisture. Keep out of reach of children.
Dosage should be determined by a healthcare professional and individualized to the patient's needs and response.
Start with a low dose and gradually increase as directed by your doctor.
Swallow tablets whole with water; do not crush, chew, or break them.
Akathisia (restlessness)
Somnolence (sleepiness)
Weight gain
Extrapyramidal symptoms (EPS) such as Parkinsonism
Nausea
Constipation
Dizziness
Sedation
Avoid alcohol consumption while taking Cariprazine as it can increase the risk of sedation and other side effects.
Avoid driving or operating machinery until you know how Cariprazine affects you. It can cause drowsiness and dizziness.
Inform your doctor immediately if you are pregnant, plan to become pregnant, or are breastfeeding. The use of Cariprazine during pregnancy and breastfeeding should be carefully considered.
Cariprazine is not approved for use in children.
Patients with kidney impairment may require dose adjustments. Consult your physician.
Patients with liver impairment may require dose adjustments. Consult your physician.
Consult your physician or pharmacist for detailed information and complete prescribing information.
